Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

    Tumor Board

    • Home
    • Tumor Board
    A modern, multi-story medical research center is illuminated at dusk, with large glass windows and well-lit interiors. The building is labeled “Houston Methodist Research Institute.” City lights are visible in the background.
    Tumor Board, Research

    Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

    July 22, 2025 joshs Comments Off on Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

    We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach. These new members, along with our existing institutions, greatly enhance our ability to develop and implement cutting-edge, individualized treatment plans.

    A doctor in a white coat with a stethoscope around their neck holds a digital tablet, standing near a window. Only the upper body is visible. Another hand is blurred in the foreground.
    Tumor Board

    Synovial Sarcoma Tumor Board Gains Widespread Adoption

    February 20, 2025 joshs Comments Off on Synovial Sarcoma Tumor Board Gains Widespread Adoption

    The Synovial Sarcoma Tumor Board, funded by the Spence Family Synovial Sarcoma Foundation, has become an essential collaborative hub for leading medical institutions across the country. This initiative, launched in partnership with CHOP and Penn Medicine, brings together top specialists to discuss complex Synovial Sarcoma cases, ensuring that patients receive expert-reviewed treatment recommendations regardless of […]

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (6)
    • Dr. Theodore Laetsch (3)
    • Education (7)
    • Healthcare (7)
    • Latest News (8)
    • Rare Cancer (1)
    • Research (15)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A scientist wearing blue gloves and safety goggles uses a pipette to place a sample on a glass slide under a microscope, with test tubes in a rack visible in the background.
      Synovial Sarcoma Research Pipeline Grows as 15+ Companies Develop New Therapies
    • A person in a lab coat and blue gloves is placing a test tube into a blue rack in a laboratory setting, with lab equipment visible in the background.
      Targeted Therapy Shows Promise in Rare BRAF-Mutated Synovial Sarcoma
    • A stethoscope rests on an open medical chart with a pen nearby, symbolizing healthcare, diagnosis, and medical documentation.
      Synovial Sarcoma Treatment Market Growth Reflects Expanding Research

    Tags

    Afami-cel BRAF mutated synovial sarcoma Callan Spence cancer-testis antigen Chas Spence CHOP Clinical Trials ground breaking human cell therapy immune-cell therapy immunotherapy Infant innovate treaments MAGE-A4 Market Growth Monophasic Synovial Sarcoma Nathan Imperiale National Tumor Board new treatments for synovial sarcoma P300 Parotid Gland patient advocates Patient Stories Prasterone Rare Cancer rare cancer clinical trials rare soft tissue sarcoma research Synovial Sarcoma synovial sarcoma case report synovial sarcoma clinical trials Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment synovial sarcoma treatment market T-Cell Therapy targeted cancer therapy targeted therapies for sarcoma targeted therapy TCR-NK TECELRA UK’s Rare Cancers Bill webinar Zelluna ZI-MA4-1

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch